Skip to main content

Advertisement

SpringerLink
Log in

Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Our study aimed to determine whether proatherogenic lipid profiles exist in patients with active Takayasu arteritis (TA) and assess the relationship between different lipid profiles and disease activity in TA. A total of 132 premenopausal female patients with TA and 100 sex-, age-, and body mass index-matched healthy controls were included in our study. The clinical data were collected in detail from all participants. Patients with active TA had significantly lower levels of apolipoprotein A1 (apoA1) (1.47 ± 0.30 vs. 1.99 ± 0.33 mmol/L, p < 0.001) and lower levels of high-density lipoprotein cholesterol (HDL-C) (1.23 ± 0.33 vs. 1.68 ± 0.38 mmol/L, p < 0.001) than patients with inactive TA. However, they had higher ratios of apolipoprotein B (apoB)/apoA1 (0.74 ± 0.27 vs. 0.48 ± 0.14, p < 0.001) compared with patients with inactive TA. Multiple linear regression analysis demonstrated that the apoB/apoA1 ratio was independently associated with TA activity (β = 0.38, p = 0.04). In addition, multivariate stepwise forward regression analysis showed that the apoB/apoA1 ratio was the major determinant for high-sensitivity C-reactive protein (β = 0.58, p = 0.002). Our findings indicate that patients with active TA had proatherogenic lipid profiles. In addition, the ratio of apoB to apoA1 could be used as a marker for monitoring and targeting patients with TA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Subramanyan R, Joy J, Balakrishnan KG (1989) Natural history of aortoarteritis (Takayasu’s disease). Circulation 80:429–437

    Article  CAS  PubMed  Google Scholar 

  2. Park KC, Kim JH, Yoon SS, Heo SH (2008) Takayasu’s disease presenting with atherothrombotic ischaemic stroke. Neurol Sci 29:363–366

    Article  PubMed  Google Scholar 

  3. Seyahi E, Ugurlu S, Cumali R, Balci H, Seyahi N, Yurdakul S et al (2006) Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 65:1202–1207

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Numano F, Okawara M, Inomata H, Kobayashi Y (2000) Takayasu’s arteritis. Lancet 356:1023–1025

    Article  CAS  PubMed  Google Scholar 

  5. Raninen RO, Kupari MM, Hekali PE (2002) Carotid and femoral artery stiffness in Takayasu’s arteritis. An ultrasound study. Sacnd J Rheumatol 31:85–88

    Article  Google Scholar 

  6. Park SH, Chung JW, Lee JW, Han MH, Park JH (2001) Carotid artery involvement in Takayasu’s arteritis: evaluation of the activity by ultrasonography. J Ultrasound Med 20:371–378

    CAS  PubMed  Google Scholar 

  7. de Carvalho JF, Bonfá E, Bezerra MC, Pereira RM (2009) High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clin Rheumatol 28:801–805

    Article  PubMed  Google Scholar 

  8. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134

    Article  CAS  PubMed  Google Scholar 

  9. Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54(Suppl):S155–S163

    Article  PubMed  Google Scholar 

  10. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M et al (1994) Takayasu arteritis. Ann Intern Med 120:919–929

    Article  CAS  PubMed  Google Scholar 

  11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) JAMA 285:2486–2497

    Article  Google Scholar 

  12. Tani S, Saito Y, Anazawa T, Kawamata H, Furuya S, Takahashi H et al (2011) Low-density lipoprotein cholesterol/apolipoprotein B ratio may be a useful index that differs in statin-treated patients with and without coronary artery disease: a case control study. Int Heart J 52:343–347

    Article  CAS  PubMed  Google Scholar 

  13. Kim SW, Jee JH, Kim HJ, Jin SM, Suh S, Bae JC et al (2013) Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Int J Cardiol 3:2678–2683

    Article  Google Scholar 

  14. Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, Ohrvik J et al (2009) Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur Heart J 30:710–717

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Mattsson N, Magnussen CG, Rönnemaa T, Mallat Z, Benessiano J, Jula A et al (2010) Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study. Arterioscler Thromb Vasc Biol 30:1861–1866

    Article  CAS  PubMed  Google Scholar 

  16. Paradis ME, Badellino KO, Rader DJ, Deshaies Y, Couture P, Archer WR et al (2006) Endothelial lipase is associated with inflammation in humans. J Lipid Res 47:2808–2813

    Article  CAS  PubMed  Google Scholar 

  17. de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E (2004) Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 50:3610–3615

    Article  PubMed  Google Scholar 

  18. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR et al (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45:1169–1196

    Article  CAS  PubMed  Google Scholar 

  19. Dullaart RP, Perton F, Kappelle PJ, de Vries R, Sluiter WJ, van Tol A (2010) Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men. Biochim Biophys Acta 1801:84–88

    Article  CAS  PubMed  Google Scholar 

  20. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C et al (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88:2527–2533

    Article  CAS  PubMed  Google Scholar 

  21. Sniderman AD (2005) Apolipoprotein B versus non-high-density lipoprotein cholesterol—and the winner is…. Circulation 112:3366–3367

    Article  PubMed  Google Scholar 

  22. Faraj M, Messier L, Bastard JP, Tardif A, Godbout A, Prud’homme D et al (2006) Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women. Diabetologia 49:1637–1646

    Article  CAS  PubMed  Google Scholar 

  23. Onat A, Can G, Hergenç G, Yazici M, Karabulut A, Albayrak S (2007) Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int J Obes 31:1119–1125

    Article  CAS  Google Scholar 

  24. Seko Y (2007) Giant cell and Takayasu arteritis. Curr Opin Rheumatol 19:39–43

    Article  PubMed  Google Scholar 

  25. Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD (2004) The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42:1355–1363

    Article  CAS  PubMed  Google Scholar 

  26. Blum A, Shamburek R (2009) The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis 203:325–330

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study is upported by the National Natural Science Foundation of China (grant no. 81170285) and the Research Fund for the Doctoral Program of Higher Education of China (grant no. 20101106110012).

Disclosures

None.

Author information

Authors and Affiliations

  1. State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Beijing, 100037, China

    X. Wang, B. Chen, N. Lv, Q. Liu & Aimin Dang

Authors
  1. X. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Q. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aimin Dang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aimin Dang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Chen, B., Lv, N. et al. Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis. Clin Rheumatol 34, 1243–1248 (2015). https://doi.org/10.1007/s10067-014-2819-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-014-2819-4

Keywords

Search

Navigation